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m99034 Postischemic Myocsrdisl Contractile Dysfunction
in the Double Heert Model. Role of Catecholamines
T.M. Frank, V. Stengl, R. Kaestner, T. Berndt, H. Hess, S.B. Felix,
G. Baumann. Charit6, Humbokft-Universitat, Berlin, Germany
We have previously reported that after global ischemia (IS) cardiodepressive
mediators are released during reperfusion. In the present study, we inves-
tigated whether the cardiodepressive effects of these mediators depend on
the duration of IS. Particular interest wae focuaaed on the modulating effects
of myocardial oetecholamines (C) during reperfusion. Two ikolated guinea
pig hearts were serially perfused by the Langendorff technique at constant
flow (10 mi/min) with a modified Krebs-Henseleit-solution. The coronary ef-
fluent (CE) of the first heart (Hi) was collected, reoxygenized and rapidly
transported to the second heart (H2). After 10 min IS of HI (n = 6) serial
perfusion induced a reversible decrease of left ventricular systolic pressure
(LVSP) (basal 69 * 5 mmHg, SEM) by 20%, +LVdP/df~sX(basal 1592 + 77
mmHg/s) by 46%, -LVdP/dt~w (basal 1370 * 117 mmHg/s) by 43% and
coronary perfusion preasure (CPP) (basal 66 + 6 cmHzO) by 23Y0in H2.
However, after 30 min IS of HI (n =5) LVSP,+LVdP/dt~w, –LVdP/dtma. of
H2 reversibly increased by24%, 60%and 24%, respectively. In the presence
of the p-blocker metoprolol (2.8 #mol/1, n = 5), these positive inotropic ef-
fects were reversed, resulting in a pronounced decrease in contractility. High
performance liquid chromatography of the CE of H1 revealed an ischemia-
inducad time-dependent release of C from isolated hearts: After 10 min of IS
no C were detected in the CE. Incontrast,affer30 minof IS theconcentration
of C inthe CE increasedwithin30s to 8104 l 324 pg/ml.
Cone/uaion:Cardiodepressive mediators are released from postischemic
myocardial tissue during reperfusion. After prolonged IS (30 rein) these
oardiodepressive effects are counteracted by catecholamines.
a99035 A Comparative Study of Troponin I and Troponin TRelease in Acute Myocerdial Infarction
B.U. Goldmann, C. Heeschen, R.H. M611er,C.W. Harem. University Hoepifa/
Eppandofi Dept. of Cardiology, Hamburg, Germany
In acute myocardial infarction (AMI) troponin T (TnT) (31 kD) and troponin
I (Tnl) (22.5 kD) are released into circulation and represent highly specific
markers for myocardial cell damage. Differences in release kinetics with
relevance to clinical diagnostics have been so far unknown. In this study
a newly developed one step solid phase enzyme immunoassay (EIA) with
highly specific monoclinal antibodieafor Tnl measurement (cut-off0.1 nglml)
in AMI was comparedwith the TnT ELlSA (cut-off0.1 nglml). in n = 141
patients(pts) withconfirmedAMI serumTnl and TnT measurements were
performed at admission (3 + 2 houra (hrs) after onset of symptoms)and after
a 4 hra interval. Resu/ta:
AMIn= 141pts TrrTz 0.1n~ml Trrl ? 0,1 nglml p value
Admission n = 94 (67°/0) n = 109 (77°/0) 0.046
+ 4 hrs interval n = 125 (69°/0) n = 137 (97%) 0.005
Serum levels at admission (+4 hrs) were 0.6+ 1.3 (5.9+ 12.8) rig/ml for
TnTand 1.7 *2.O (12.7 &27.4) rig/ml for Tnl. Tnl increased earlier than TnT
and revealed a higher diagnostic sensitivity for AMI.
Cone/uaion: Based on these quantitative assays Tnl was the superior
marker for the early bicxhemical detection of AMI. The potential advantage
of Tnl as a serodiagnostic tool for therapeutic management of patients pre-
senting with early onset of AMI deserves further clinical evaluation.
D99036 Neopterin, a Serum Marker of Immune Activation,
is Elevated in Acute Coronsry Syndromes
S. Gupta, S. Fredericks, R.A. Schwartzman, E.W. Leatham, M. Mendall,
R. Crook, N. Ireson, J. Morris, D.W. HoIt, J.C. Kaski. St George’s Hospital,
London, UK
There isgrowingevidence foran immunological basis forthepathophysiology
of acute coronary syndromes. Neopterin is a sensitive serum marker for the
activation of the cellular immune system. The relative activity of neopterin
in acute and chronic ischaemic hearI disease (IHD) was investigated in this
study. Neopterfn was measured by ELlSA in the serum from 87 male cardiac
patients. These included those with acute myocardial infarction (group AMI,
n = 10), previous myocardial infarction (>6 months previously, group PMI, n
= W) and unstable angina (group UA, n = 17). Neopterin levels were also
measured in a matched control group (NC, n = 42) with no evidence of
IHD. Results are expressed as neopterin/creatinine ratios (mean + SEM),
correcting for renal function in all subjects.
Serum neopterin was significantly elevated in both the UAand AMI groups
compared to PMI and NC groups. There was no difference in levels between
UAVSAMI orPMl vs NC. Cone/usiorr:Thestudy findings support the evidence
Neop/Creat (nmollpmol)
0.251 l
0.20
0.15-
NC PMI UA AMI
.P. 0.001 VSNC and PMI,#p<O.006VSPMI, -F= 0.02 VSNC
for the role of the cellular immune system in the pathophysiology of acute
coronary syndromes.
~990-371Theparticipationof Fae/Fasli~and system in
apoptosis of cardiomyocytes in humsn scute
myocardial infarction
T, Shimojo 1,2,T. Nishikawa 1, S, Ie.hiyama1,2,H. Itoz, T. Kasajima 1,
F.Marumo2, M. Hiroe2. (l) Tokyo VVomenkMedics/ Co//ege, Tokyo,Japan,
(2)TokyoMedk?elandDental University, Tokyo,Jepan
There aretwotypesof cell death, necrosis, and apoptosis. Itwas repotted that
apoptosis occurs in cardiomyocytes by hypoxia and ischemia, and in acute
myocardial infarction (AMI), concomitant with necrotic myocyte cell death.
However, the molecular mechanism of the apoptotic cell death is remains
unclear in myocardial ischemia and infarction. The Fas molecule is a tumor
necrotic factor receptor family protein and produces a signal for apoptosis
induction after binding to Fas Iigand (L). In the present study, we investigated
whether the Faa/FasLsystem is associated with apoptotic cell death of hearta
following AMI. Lelt ventricular specimens obtained from 10 patients died of
AMI were used for detection of apoptosis using agarose-gell electrophoresis
and the terminal deoxynucleotidyl transfarase assay (TUNEL). Moreover, the
expression of Fas and Fas L proteins, and T lymphocyte surface markers
was examined by immunohistochemistry. Nuclear DNA electrophoretic anal-
ysisconfirmed nucleosomal iadders intheaffected area. The TUNELpositive
cells were observed in the numerous cardiomyocytes and lymphocytes of the
periinfarcted area, but not in the non-infarct myocardium. lmmunohistochem-
ical study showed strongly positive staining for Fas in the myocytes facing
to the infarct and infiltrating lymphocytes. Fas L positive lymphocytes were
classified as GD4+ and GD8+ T cells. These results incidate that Fae/Fas
Iigand system participates in apoptosis in human myocardium in AMI. These
results suggest that the FaeJFasL system is related to apoptotic cell death
as a mechanism of cardiac injury following AMI.
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1991-13] Early Combined Electrocardio~raphic and
Biochemical Risk Stratification of Patients with
Unstsble Coronary Artery Disease - A TRIM
Substudy
L. Holmvang, M. Li.ischer,K. Thygesen, G. Wagner, P.Grande. The Hear?
Centec The National University Hospital, Copenhagen, Denmark,
Depafiment of Cardiology Asrfrus Amtssygehus, Aarhus, Denmark
The present study investigates, whether the combination of a standard ECG
and very early measurements of new, biochemical markers of iachemiacould
improve the identification of a high tisk population in patienta admitted with
unstable coronary artery disease, ie non-Q Ml or unstable angina. Methods:
516 patients were included. Electrocardiographic analysis: All patients had
an ECG obtained at admission. The patients were divided into two subgroups
based on whether they had significant ST-aegment depression or not. Bio-
chenrica/ana/ysis: At admission and 6 hours later blood samples were drawn
and analyzed for myoglobin, Troponin T (TnT), Troponin I (Tnl) and CK-MB
mass concentration. Endpoints: Death, myocardial infarction or refractory
angina leading to acute intewention during a 30 days follow-up period. Re-
sults: The predictive value of ST-depression in the baseline ECG was 0.24.
Only Myoglobin and TnT were increased among the patients suffering an
event. Cut-off values for identifying a high risk patient were set at 0.1 @L
(TnT) and 80 ~g/L (Myoglobin).
JACC February 1997 ABSTRACTS - Poster 273A
Variable,n Eventa, n Ibg rank event
(predictivevalue) analysis,p
ST-deoreeeionin baseline ECG, n = 59 14 (0.24) 0.0003
TnT >’0.1 J@L, n = 246
Myoglobin>60 L@/L,n = 117
TnT >0.1 L@L or Mycglobin>60 y@L, n = 262
ST-depressionorTnT >0.1 @L, n = 256
ST-depressionor Myoglobin>60 j@L, n = 145
TnT >0.1 L@/Lend Myoglobin>80 #g/L, n = 101
ST-depressionand TnT >0.1 jLglL,n =47
ST-deoreseionand Mvodobin >60 wtlL, n =31
ST-dep;ess. orTnT o~M~oglobin,n =>72
31 io,13j
16 (0.15)
34(0.13)
33 (0.13)
24 (0.17)
16 (0.16)
13(0.28)
6 (0.26)
34 (0.13)
0.07
0,04
0.08
0.06
0.004
0.04
oOoo#
0,003
0.1
Conclusion: Early measurements of Myoglobin and TnT carry indepen-
dent prognostic information in patients with unstable corona~artery disease.
The combination of these biochemical markers of ischemia and the ECG
identifies a subgroup at high risk for auffering early cardiac events. However,
the ECG is still the best individual predictor of peer outcome.
1991-141 Dobu*amineSt~e~~ E~h~~a~di~g~aPhYf~~R,~k
Stratification of Patiants with Unstable Angina
A.A. Awan, L.D. Gillam, R. Goldman, T. Shuaib, Z. Mirza, J. Quion,
A. LaSala, D. Waters, C. Chen. f-ksr?fordFfospita/,Harlford, CT USA
Toaseesethesafety and utility of dobutamine stress echocardiography (DSE)
forriskstratification of patients (pts) with unstable angina. Thiestudy included
109 pts (age: 61 +12 yeara, 57 males) with admission diagnosis of unstable
angina, in whom DSE was performed after stabilization of symptoms for at
leaat 24 houra. Pts were followed for 1-2.5 yeare. Results: DSE caused
no major complications (death, infarction or arrhythmia requiring treatment).
DSE was positive for ischemia in 68 pts and negative in 41 pts. During
follow-up, there were 7 pte with cardiac deathe/fatal infarctions, 32 rehos-
pitalization for recurrent angina, myocardial infarction an~or congestive
heart failure, and 21 revascularizations (19 surgical, angioplasty = 2). One of
the 41 pts with negative DSE had recurrent angine/congestive heart failure
leading to readmission to a hospital for revascularization without any death
during follow-up. In contrast, in 6S pts with a poeitive DSE, 7 pts died (p
< 0.05), 20 pts underwent revascularization (p < 0.01) and 31 pts required
hospital readmission with recurrent chest pain, infarction and/or congestive
heart failure (p < 0.01). Negative predictive value of DSE for cardiac event,
revascularization or readmission was 97.6% and positive predictive value
was 57% with accuracy of 72%.
Cpnc/uaions: In unstable angina pts whose symptoms have been stabi-
lized for at least 24 hours, DSE appeara safe. A positive responee indicative
of ischemia occurs in about two thirds of caees and accurately predicted
cardiac death, recurrent events requiring hospitalization and/or revascular-
ization during 1-2.5 years of follow-up. In contrast, a negative DSE is highly
predictive of a benign outcome.
D991 15 Prahoapital Troponin TTeet in Patienta WithSuspeoted Acute Myocardial Infarction
A. Schuchert, C. Harem, J. Scholz, S. Klimmeck, B. Goldmann, T. Meineitz.
Depsr?.of Cardiology, UKE, Hamburg, German& Depart. of Anesthesiology,
UKE, Hamburg, Germany
Cardiac troponin T (TnT) is an early marker for acute myocardial infarction
(AMI). We investigated whether a rapid qualitative assay for the detection of
serum cardiac TnT (TROPTR)(detection limit 0.18 rig/ml) in the ambulance
car helps to verify AMI very earfy in 158 patients (pts) with suspected AMI
(male n = 93;89•13 years). A 2nd TnT-test wae performed within 3 hours
after admission to the emergency room of a hospital. An AMI was defined
either by new Q-waves or new negative T-waves in the ECG combined with
an increase of CK > 150 WI and an increaee of CK-MB =- 6Y0.An AMI
wae excluded in the absence of these findings. Combined studied endpoints
were death or definitive AMI from 2nd day in-hospital until 6 month follow-up.
Follow-up included 153 pts.
Results: There were 40 pts with AMI, 118 pte without AMI. Prehospital
TnT-test was positive in 7 pts with AMI (18%) and in 4 without AMI (3%).
The second test at hospital admission was positive in 39 pts with AMI. In pts
without AMI the 2nd test was positive in 14 (12%) and negative in 104 (88%)
pts. In the latter group 5 pts were lost from follow-up. In pts without AMI,
cardiac events within the next 6 months occurred more offen in pts with a
positive (n= 7/14) than in pts with a negative TnT-test (n = 16/99; p c 0.05).
Conclusions: The prehospital TnT-test was positive in only the minority
of the pte with AMI. The second TnT-test at hospital admission detected in
WOA the pts with AM]. Pts in whom an AMI was excluded, but with afJOSitiVO
TnT-teet at hospital admission, had an increased risk for death or AMI within
the next 6 monthe.
[991-161lndaPsndentLong-Term pro9nosticVa,ueof
Troponin Tfor Cardiac Outcomea Aftar Noncardiac
Surgary
F. Lopez-Jimenez, L. Goldman, E.J. Thomas, P.Johneon, K.M. Kuntz,
D.B. Sacks, T.H, Lee. Brigham and Women’s Hospital, Boston, MA, USA,
UCSE San Francisco, CA, USA
Toevaluatethe6-month prognostic significance of abnormal troponin T (TnT)
serum levels, we etudied 772 patients (49% female, mean age 66.7 + 11
years) who underwent rnsjor noncardiac surgery without major cardiac com-
plications. Clinical data were obtainad preoperatively via a structured history
and physical examination. The protocol for measurement of total serum cre-
atine kinase (CK), CK-MB and TnT included samples in the recovery room
and on the following two mornings. Six-month follow-up data on vital status
and clinical complications were collectad via interview for 722 (94%) pa-
tients. A search of the Massachusetts Registry of Deaths was performed to
confirm death and to search for patients lost to follow-up. Classification of
cause of death and major cardiac complications was performed by reviewers
blinded to TnTand CK-MB values. Abnormal values of TnT (z-O.1rig/ml) and
CK-MB (>8 U/L with ion-exchange chromatography assay or >5 ng/mL for
mass assay) were detected for 92 (12%) and 211 (27%) patients, respec-
tively. During the six-month follow-up period, 19 (2.5%) patients had major
cardiac complications, including 14 cardiac deaths, 3 non-fatal myocardial
infarctions and 2 admissions for unstable angina. Elevated Tn? values were
detected for 8/19 patients with complications (sensitivity = 42%; specificity
= 89%; positive predictive value [PV+] = 9%; PV– = 98%; relative risk =
5.4). For CK-MB, corresponding test characteristics were 32%, 73%, 3%,
98%, and 1.2, respectively. Multivariate analysis indicated that TnT was an
independent correlate of outcome after adjusting for preoperative clinical and
CK-MB data. This correlation was a function of the relationship of elevated
TnT levels with postoperative inhospital heart failure and arrhythmias. These
data suggest that TnT elevations may reflect ischemia that did not lead to
CK-MB elevations.
/991-171 MinirnalElevation of TropOninlonAdrnisaion
Identifies Patienta at Risk for Adverae Cardiac
Outcomes
R.L. Jesse, M.C. Kontos, D.J. Zhang, J.P. Ornate, J.L. Tatum, P.Anderson.
Medical College of ViginiaWCU, Richmond, VA, USA
Itis unknown whether minor elevations in Troponin I (Tnl) areassociated with
an increased incidence of adverse cardiac evants. Methods: We measured
cardiac Tnl in the admission blood sample from 466 patients (pts) admitted
for poesible myocardial infarction (Ml). Ml was diagnosed by conventional
criteria. Results: Of 466 pts studied, 67 Nled-in for ML Tnl was 22.0 ng/mL
(lower limit for Ml) in 62 pts, ”including 76% with ML In 21 pts Tnl was ?1.0
but <2.0 ngfmL, including 29% having ML Only 10 of the 463 pts (2.2%) with
Tnl <1.0 ng/mL had Ml. A total of 132 pts (29%) had cardiac eventa (Ml,
revascularization or death). Number of events and relative risks (compared
to pts with Tnl < 1.0) are shown in the Table.
Tnl lna/mL) N Cardiac Events Relative Risk
22.0 62 55 (89”A) 38
1,0s Tnl <2.0 21 11 (53%) 5.3
< 1,0 363 66 (17”/4 1.0
Adverse cardiac events were significantly higher in pte with Tnl ? 2.Othan
in pts havingeither intermediate (p <0.001) or low (p <0.0001) Tnl. However,
the event rate in pts with intermediate Tnl was significantly higher than in
pts with low Tnl (p < 0.001). Conclusion: At the time of admiseion, minor
elevations of Tnl that are leas than the defined Ml threshold are associated
with an increased incidence of adverse cardiac events.
D991 18 Noninvaaive Tests After Myocardial Infarction in
tha Thrombolytic Era: Prognostic Valua and
Ralative Cost
R.F.E.Pedretti, O. Catalano, S.S. Braga, R. Tramarin. Sa/vatore Maugeti
Foundation, Care and Reaearch hrstitute, Cardiology Dpt, Rehabilitation
Institute, Tradate, Italy
The prognostic value and relative cost of noninvasive tests after Ml was
evalusted in 536 consecutive patients, 263 (53%) treated with thromboly-
sis, eligible for cardiac rehabilitation. At 2-year follow-up, 26 (5%) pts died
from cardiac death. Cox regression analysis selected variables to build prog-
nostic models and the model predictive accuracy was evaluated by logistic
regression and receiver-operator characteristic curve area (ROCca). Costs
of noninvasive tests, relative to that of a resting ECG, were obtained from
literature.
